跳至主要内容
临床试验/CTRI/2020/03/024184
CTRI/2020/03/024184尚未招募未知

Dose Escalated Radiotherapy and Organ Preservation in Rectal Cancers (DEROP-RC) - DEROP-RC

Tata Memorial Hospital0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Clinical Stage T2-T3
  • -Histologically confirmed diagnosis of adenocarcinoma of the rectum
  • -The distance from anal verge of tumor upto 10 cm(Mid and low rectal tumors)
  • -Palpable upper limit
  • -Involving less than 2/3rd of the circumference
  • -ECOG Performance status 0-1

排除标准

  • -Recurrent rectal cancer
  • -Having pathology of signet ring cell carcinoma
  • -Evidence of distant metastases
  • -Prior pelvic radiotherapy, chemotherapy or surgery for rectal cancer
  • -Creatinine level greater than 1.5 times the upper limit of normal.
  • -Patients who are unable to undergo an MRI.
  • -Patients with a history of a prior malignancy within the past 5 years, except for adequately treated basal cell or squamous cell skin cancer.
  • -Patients with a history of any arterial thrombotic event within the past 6 months. This includes angina (stable or unstable), MI, TIA, or CVA.
  • -Other Anticancer or Experimental Therapy.
  • -Women who are pregnant or breast-feeding.
  • -Patients with any other concurrent medical or psychiatric condition or disease which would make them inappropriate candidates for entry into this study.
  • -Not willing to consent for the study
  • -Unreliable for close follow up

研究者

相似试验

Increasing dose of radiation in rectal cancer... | 临床试验